Select Net Income Applicable To Common Shares from 2010 to 2026
| SEM Stock | USD 15.64 0.05 0.32% |
Net Income Applicable To Common Shares | First Reported 2006-03-31 | Previous Quarter 39.8 M | Current Value 28.1 M | Quarterly Volatility 31.8 M |
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.7 M, Interest Expense of 151.7 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.029 or PTB Ratio of 1.37. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
Select | Net Income Applicable To Common Shares | Build AI portfolio with Select Stock |
Evaluating Select Medical's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Select Medical Holdings's fundamental strength.
Latest Select Medical's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Select Medical Holdings over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Select Medical's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Select Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 171,237,448 | |
| Geometric Mean | 153,078,091 | |
| Coefficient Of Variation | 48.07 | |
| Mean Deviation | 59,710,490 | |
| Median | 148,449,000 | |
| Standard Deviation | 82,317,337 | |
| Sample Variance | 6776.1T | |
| Range | 366.8M | |
| R-Value | 0.63 | |
| Mean Square Error | 4351.6T | |
| R-Squared | 0.40 | |
| Significance | 0.01 | |
| Slope | 10,283,191 | |
| Total Sum of Squares | 108418.3T |
Select Net Income Applicable To Common Shares History
About Select Medical Financial Statements
Select Medical investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 243.5 M | 163.7 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Select Medical Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Health Care Providers & Services sector continue expanding? Could Select diversify its offerings? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Select Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.47) | Dividend Share 0.375 | Earnings Share 0.82 | Revenue Per Share | Quarterly Revenue Growth 0.072 |
Investors evaluate Select Medical Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Select Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Select Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Select Medical's market price signifies the transaction level at which participants voluntarily complete trades.